SEBI Examining Whistleblower Complaint Against Sun Pharma, Says Chairman Tyagi
A security guard stands beside signage outside the Sun Pharmaceutical Industries Ltd. corporate office in the Andheri suburb of Mumbai. (Photographer: Amit Madheshiya/Bloomberg)

SEBI Examining Whistleblower Complaint Against Sun Pharma, Says Chairman Tyagi

Bookmark
Markets regulator Securities and Exchange Board of India on Wednesday said it is examining the whistleblower complaint against Dilip Shanghvi-led Sun Pharmaceutical Industries Ltd.A whistleblower h...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.